TissueTinker Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $4K

  • Investors
  • 3

TissueTinker General Information

Description

Developer of a 3D bioprinted modeling platform designed to capture key aspects associated with cancer growth and metastasis to replicate human cancer. The company's platform constructs tumor organoids that allow for natural cell-to-cell signaling and growth than can be achieved in traditional 2D cell cultures, develops curated panels for nanoparticles and small molecule drugs and new therapeutics for underserved cancers by leveraging our backgrounds in technology, enabling healthcare professionals to accelerate cancer therapeutic development through validated and democratized preclinical technology.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 1650 Avenue Cedar
  • Montreal, Quebec H3G 1B3
  • Canada
Primary Industry
Biotechnology
Corporate Office
  • 1650 Avenue Cedar
  • Montreal, Quebec H3G 1B3
  • Canada

TissueTinker Timeline

202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TissueTinker Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 30-Jan-2025 $4K Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2025 Completed Generating Revenue
3. Grant 01-Jan-2024 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2024 Completed Generating Revenue
1. University Spin-Out 01-Jan-2023 Completed Startup
To view TissueTinker’s complete valuation and funding history, request access »

TissueTinker Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TissueTinker Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
University of New Brunswick University
Centech Accelerator Accelerator/Incubator
McGill University University
To view TissueTinker’s complete investors history, request access »

TissueTinker FAQs

  • When was TissueTinker founded?

    TissueTinker was founded in 2023.

  • Where is TissueTinker headquartered?

    TissueTinker is headquartered in Montreal, Canada.

  • What is the size of TissueTinker?

    TissueTinker has 5 total employees.

  • What industry is TissueTinker in?

    TissueTinker’s primary industry is Biotechnology.

  • Is TissueTinker a private or public company?

    TissueTinker is a Private company.

  • What is TissueTinker’s current revenue?

    The current revenue for TissueTinker is .

  • How much funding has TissueTinker raised over time?

    TissueTinker has raised $6.96K.

  • Who are TissueTinker’s investors?

    University of New Brunswick, Centech Accelerator, and McGill University have invested in TissueTinker.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process